Skip to content

Clinical trials

Phase 3 Malaria, Falciparum trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Malaria, Falciparum Phase: Phase 3 Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20041
20053
20063
20074
20091
20102
20113
20133
20142
20172
20182
20192
20204
20213
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Unknown status5
Active, not recruiting1
Suspended1
Withdrawn1
Recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London School of Hygiene and Tropical Medicine11
GlaxoSmithKline7
University of Oxford7
Medicines for Malaria Venture2
National Institute of Allergy and Infectious Diseases (NIAID)2
Centro Internacional de Entrenamiento e Investigaciones Médicas1
Dafra Pharma1
Indiana University1
Institut de Recherche en Sciences de la Sante, Burkina Faso1
National Institute for Medical Research, Tanzania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Malaria, Falciparum45
Malaria30
Anemia5
Malaria, Vivax4
Protozoan Infections2
Acute Kidney Injury1
Ancylostomiasis1
Asymptomatic Infections1
Cardiotoxicity1
Elephantiasis, Filarial1

Trials

Showing 51 to 45 of 45. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.